30 Day Trial
ORTHOWORLD Press Releases


CHAGRIN FALLS, Ohio, June 17 /PRNewswire --  "Comparative Effectiveness will have the most significant impact on the orthopaedic industry moving forward," noted John Engelhardt  in his luncheon Keynote Address today at the 6th Annual Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC) in Chicago, Illinois. Mr. Engelhardt, CEO of ORTHOWORLD Inc. and Managing Member of Knowledge Ventures, LLC, emphasized that industry will be compelled to adopt the concept of comparative effectiveness throughout its business models in order to gain the efficiencies required to thrive in the future.

"With so little accurate, specific information available on the impacts of healthcare 'reform,' accepting Comparative Effectiveness as 'inevitable' enables industry to take action and advance on at least one element," commented April Bright, General Manager of ORTHOWORLD.

Mr. Engelhardt went on to acknowledge that the task of proving clinical and economic benefits will reveal further opportunities.

John Engelhardt is one of more than 20 thought leaders presenting to hundreds of orthopaedic industry device company decision makers at OMTEC in Chicago, Illinois on June 16 and 17. For more information about OMTEC, please visit the ORTHOWORLD website at www.orthoworld.com.


Founded in 1992, ORTHOWORLD is the only producer of strategic intelligence in the world solely focused upon the orthopaedic industry. Its singular mission is helping orthopaedic companies and individuals improve their performance.

For personal assistance, contact:
Julie Vetalice